Search research articles
Contact Us
Filters
Showing results (411-420 of 563) with videos related to
Page
of 57
Sort By:
Antiviral Research
|
October 1, 1994
9-(2-Phosphonylmethoxyethyl) adenine increases the survival of influenza virus-infected mice by an enhancement of the immune system
N Villani, R Caliò, E Balestra, et al.
Journal of Medicinal Chemistry
|
August 1, 1989
Synthesis and antiviral activity of 3'-C-cyano-3'-deoxynucleosides
M J Camarasa, A Diaz-Ortiz, A Calvo-Mateo, et al.
Virology
|
October 12, 2007
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes
M Pollicita, D Schols, S Aquaro, et al.
Nucleic Acids Symposium Series
|
January 1, 1991
Investigation of DNA biosynthesis catalyzed by DNA polymerases: approach of synthesis of compounds with anti-HIV activity
A A Krayevsky, N B Tarussova, M K Kuhanova, et al.
European Journal of Medicinal Chemistry
|
March 13, 2012
Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants
I Perković, I Butula, M Kralj, et al.
British Journal of Haematology
|
November 13, 2001
Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?
K Spaepen, S Stroobants, P Dupont, et al.
Antiviral Research
|
April 1, 1992
Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages
C F Perno, R Yarchoan, J Balzarini, et al.
Journal of Medicinal Chemistry
|
January 11, 2001
Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain
C McGuigan, H Barucki, A Carangio, et al.
Methods in Molecular Medicine
|
February 19, 2011
Evaluating Clinical Isolates for Their Phenotypic and Genotypic Resistance Against Anti-HIV Drugs
A M Vandamme, M Witvrouw, C Pannecouque, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1997
Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice
J Balzarini, T Vahlenkamp, H Egberink, et al.
Page
of 57
Search research articles
Search
Showing results (411-420 of 563) with videos related to
Sort By:
Page
of 57
Antiviral Research
|
October 1, 1994
9-(2-Phosphonylmethoxyethyl) adenine increases the survival of influenza virus-infected mice by an enhancement of the immune system
N Villani, R Caliò, E Balestra, et al.
Journal of Medicinal Chemistry
|
August 1, 1989
Synthesis and antiviral activity of 3'-C-cyano-3'-deoxynucleosides
M J Camarasa, A Diaz-Ortiz, A Calvo-Mateo, et al.
Virology
|
October 12, 2007
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes
M Pollicita, D Schols, S Aquaro, et al.
Nucleic Acids Symposium Series
|
January 1, 1991
Investigation of DNA biosynthesis catalyzed by DNA polymerases: approach of synthesis of compounds with anti-HIV activity
A A Krayevsky, N B Tarussova, M K Kuhanova, et al.
European Journal of Medicinal Chemistry
|
March 13, 2012
Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants
I Perković, I Butula, M Kralj, et al.
British Journal of Haematology
|
November 13, 2001
Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?
K Spaepen, S Stroobants, P Dupont, et al.
Antiviral Research
|
April 1, 1992
Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages
C F Perno, R Yarchoan, J Balzarini, et al.
Journal of Medicinal Chemistry
|
January 11, 2001
Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain
C McGuigan, H Barucki, A Carangio, et al.
Methods in Molecular Medicine
|
February 19, 2011
Evaluating Clinical Isolates for Their Phenotypic and Genotypic Resistance Against Anti-HIV Drugs
A M Vandamme, M Witvrouw, C Pannecouque, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1997
Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice
J Balzarini, T Vahlenkamp, H Egberink, et al.
Page
of 57